Jan 29 (Reuters) - Cost cuts helped U.S. drugmaker Abbvie Inc report slightly better-than-expected fourth-quarter earnings on Friday, but shares slipped nearly 3 percent as revenue fell short of expectations for a second time in the past eight quarters.
